- 米国企業
- Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc.SHPH
| 2022年 12月31日 |
---|
Research and development, net of contract expense reimbursements | 1 |
---|
General and administrative | 198,978 |
---|
Legal and professional | 866,770 |
---|
Total operating expenses | 3 |
---|
Net loss from operations | -2,554,278 |
---|
Interest expense - related parties | 52,010 |
---|
Interest expense | 917,879 |
---|
Change in fair value of warrant liability | -94,025 |
---|
Gain on settlement of accounts payable | 328,687 |
---|
Gain on forgiveness of Paycheck Protection Program note payable | 73,007 |
---|
Total other income (expense) | -474,170 |
---|
Loss before income taxes | -3,028,448 |
---|
Net loss | -3,028,448 |
---|
Dividend on Series A Preferred Stock | 71,009 |
---|
Net loss attributable to common stockholders | -3,099,457 |
---|
Net loss per shares - basic and diluted | -0.29 |
---|